0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sodium Hyaluronate (HA) for Ophthalmology Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-20O9522
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sodium Hyaluronate HA for Ophthalmology Market Research Report 2022
BUY CHAPTERS

Global Sodium Hyaluronate (HA) for Ophthalmology Market Research Report 2025

Code: QYRE-Auto-20O9522
Report
June 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sodium Hyaluronate (HA) for Ophthalmology Market

The global market for Sodium Hyaluronate (HA) for Ophthalmology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sodium hyalurate (SH) is a macromolecular mucopolysaccharide, which exists in the tissues of various animals, but it is mostly in the combs and human umbilical cord and placenta tissues.
Currently, the Sodium Hyaluronate (HA) for Ophthalmology is mainly extracted from cockscomb or prepared by fermentation.
North American market for Sodium Hyaluronate (HA) for Ophthalmology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sodium Hyaluronate (HA) for Ophthalmology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sodium Hyaluronate (HA) for Ophthalmology include Bloomage Biotech, Shandong Focuschem Biotech, Fufeng Group, Shandong Awa Biopharm, China Eastar Group, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sodium Hyaluronate (HA) for Ophthalmology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sodium Hyaluronate (HA) for Ophthalmology.
The Sodium Hyaluronate (HA) for Ophthalmology market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sodium Hyaluronate (HA) for Ophthalmology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sodium Hyaluronate (HA) for Ophthalmology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sodium Hyaluronate (HA) for Ophthalmology Market Report

Report Metric Details
Report Name Sodium Hyaluronate (HA) for Ophthalmology Market
by Type
  • Biological Extraction
  • Ferment
by Application
  • Eye Drops
  • Eye Surgery
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bloomage Biotech, Shandong Focuschem Biotech, Fufeng Group, Shandong Awa Biopharm, China Eastar Group, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici, LG Life Sciences, Haohai Biological Technology, Elravie (Humedix), SciVision Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sodium Hyaluronate (HA) for Ophthalmology manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Sodium Hyaluronate (HA) for Ophthalmology by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Sodium Hyaluronate (HA) for Ophthalmology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sodium Hyaluronate (HA) for Ophthalmology Market report?

Ans: The main players in the Sodium Hyaluronate (HA) for Ophthalmology Market are Bloomage Biotech, Shandong Focuschem Biotech, Fufeng Group, Shandong Awa Biopharm, China Eastar Group, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici, LG Life Sciences, Haohai Biological Technology, Elravie (Humedix), SciVision Biotech

What are the Application segmentation covered in the Sodium Hyaluronate (HA) for Ophthalmology Market report?

Ans: The Applications covered in the Sodium Hyaluronate (HA) for Ophthalmology Market report are Eye Drops, Eye Surgery, Others

What are the Type segmentation covered in the Sodium Hyaluronate (HA) for Ophthalmology Market report?

Ans: The Types covered in the Sodium Hyaluronate (HA) for Ophthalmology Market report are Biological Extraction, Ferment

1 Sodium Hyaluronate (HA) for Ophthalmology Market Overview
1.1 Product Definition
1.2 Sodium Hyaluronate (HA) for Ophthalmology by Type
1.2.1 Global Sodium Hyaluronate (HA) for Ophthalmology Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Biological Extraction
1.2.3 Ferment
1.3 Sodium Hyaluronate (HA) for Ophthalmology by Application
1.3.1 Global Sodium Hyaluronate (HA) for Ophthalmology Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Eye Drops
1.3.3 Eye Surgery
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Sodium Hyaluronate (HA) for Ophthalmology Production Estimates and Forecasts (2020-2031)
1.4.4 Global Sodium Hyaluronate (HA) for Ophthalmology Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Manufacturers (2020-2025)
2.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Sodium Hyaluronate (HA) for Ophthalmology, Industry Ranking, 2023 VS 2024
2.4 Global Sodium Hyaluronate (HA) for Ophthalmology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Sodium Hyaluronate (HA) for Ophthalmology Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, Product Offered and Application
2.8 Global Key Manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, Date of Enter into This Industry
2.9 Sodium Hyaluronate (HA) for Ophthalmology Market Competitive Situation and Trends
2.9.1 Sodium Hyaluronate (HA) for Ophthalmology Market Concentration Rate
2.9.2 Global 5 and 10 Largest Sodium Hyaluronate (HA) for Ophthalmology Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Sodium Hyaluronate (HA) for Ophthalmology Production by Region
3.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Region (2020-2031)
3.2.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Sodium Hyaluronate (HA) for Ophthalmology by Region (2026-2031)
3.3 Global Sodium Hyaluronate (HA) for Ophthalmology Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Sodium Hyaluronate (HA) for Ophthalmology Production Volume by Region (2020-2031)
3.4.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Sodium Hyaluronate (HA) for Ophthalmology by Region (2026-2031)
3.5 Global Sodium Hyaluronate (HA) for Ophthalmology Market Price Analysis by Region (2020-2025)
3.6 Global Sodium Hyaluronate (HA) for Ophthalmology Production and Value, Year-over-Year Growth
3.6.1 North America Sodium Hyaluronate (HA) for Ophthalmology Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Sodium Hyaluronate (HA) for Ophthalmology Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Sodium Hyaluronate (HA) for Ophthalmology Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Sodium Hyaluronate (HA) for Ophthalmology Production Value Estimates and Forecasts (2020-2031)
4 Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region
4.1 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region (2020-2031)
4.2.1 Global Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region (2020-2025)
4.2.2 Global Sodium Hyaluronate (HA) for Ophthalmology Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Type (2020-2031)
5.1.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Type (2020-2025)
5.1.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Type (2026-2031)
5.1.3 Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Type (2020-2031)
5.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Type (2020-2031)
5.2.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Type (2020-2025)
5.2.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Type (2026-2031)
5.2.3 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Type (2020-2031)
5.3 Global Sodium Hyaluronate (HA) for Ophthalmology Price by Type (2020-2031)
6 Segment by Application
6.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Application (2020-2031)
6.1.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Application (2020-2025)
6.1.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production by Application (2026-2031)
6.1.3 Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Application (2020-2031)
6.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Application (2020-2031)
6.2.1 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Application (2020-2025)
6.2.2 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Application (2026-2031)
6.2.3 Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Application (2020-2031)
6.3 Global Sodium Hyaluronate (HA) for Ophthalmology Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Bloomage Biotech
7.1.1 Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.1.2 Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.1.3 Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Bloomage Biotech Main Business and Markets Served
7.1.5 Bloomage Biotech Recent Developments/Updates
7.2 Shandong Focuschem Biotech
7.2.1 Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.2.2 Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.2.3 Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shandong Focuschem Biotech Main Business and Markets Served
7.2.5 Shandong Focuschem Biotech Recent Developments/Updates
7.3 Fufeng Group
7.3.1 Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.3.2 Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.3.3 Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Fufeng Group Main Business and Markets Served
7.3.5 Fufeng Group Recent Developments/Updates
7.4 Shandong Awa Biopharm
7.4.1 Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.4.2 Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.4.3 Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Shandong Awa Biopharm Main Business and Markets Served
7.4.5 Shandong Awa Biopharm Recent Developments/Updates
7.5 China Eastar Group
7.5.1 China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.5.2 China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.5.3 China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.5.4 China Eastar Group Main Business and Markets Served
7.5.5 China Eastar Group Recent Developments/Updates
7.6 Kewpie
7.6.1 Kewpie Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.6.2 Kewpie Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.6.3 Kewpie Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Kewpie Main Business and Markets Served
7.6.5 Kewpie Recent Developments/Updates
7.7 Contipro
7.7.1 Contipro Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.7.2 Contipro Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.7.3 Contipro Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Contipro Main Business and Markets Served
7.7.5 Contipro Recent Developments/Updates
7.8 Seikagaku
7.8.1 Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.8.2 Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.8.3 Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Seikagaku Main Business and Markets Served
7.8.5 Seikagaku Recent Developments/Updates
7.9 HTL Biotechnology
7.9.1 HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.9.2 HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.9.3 HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.9.4 HTL Biotechnology Main Business and Markets Served
7.9.5 HTL Biotechnology Recent Developments/Updates
7.10 Fidia Farmaceutici
7.10.1 Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.10.2 Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.10.3 Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Fidia Farmaceutici Main Business and Markets Served
7.10.5 Fidia Farmaceutici Recent Developments/Updates
7.11 LG Life Sciences
7.11.1 LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.11.2 LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.11.3 LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.11.4 LG Life Sciences Main Business and Markets Served
7.11.5 LG Life Sciences Recent Developments/Updates
7.12 Haohai Biological Technology
7.12.1 Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.12.2 Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.12.3 Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Haohai Biological Technology Main Business and Markets Served
7.12.5 Haohai Biological Technology Recent Developments/Updates
7.13 Elravie (Humedix)
7.13.1 Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.13.2 Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.13.3 Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Elravie (Humedix) Main Business and Markets Served
7.13.5 Elravie (Humedix) Recent Developments/Updates
7.14 SciVision Biotech
7.14.1 SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Company Information
7.14.2 SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Product Portfolio
7.14.3 SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Production, Value, Price and Gross Margin (2020-2025)
7.14.4 SciVision Biotech Main Business and Markets Served
7.14.5 SciVision Biotech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Sodium Hyaluronate (HA) for Ophthalmology Industry Chain Analysis
8.2 Sodium Hyaluronate (HA) for Ophthalmology Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Sodium Hyaluronate (HA) for Ophthalmology Production Mode & Process Analysis
8.4 Sodium Hyaluronate (HA) for Ophthalmology Sales and Marketing
8.4.1 Sodium Hyaluronate (HA) for Ophthalmology Sales Channels
8.4.2 Sodium Hyaluronate (HA) for Ophthalmology Distributors
8.5 Sodium Hyaluronate (HA) for Ophthalmology Customer Analysis
9 Sodium Hyaluronate (HA) for Ophthalmology Market Dynamics
9.1 Sodium Hyaluronate (HA) for Ophthalmology Industry Trends
9.2 Sodium Hyaluronate (HA) for Ophthalmology Market Drivers
9.3 Sodium Hyaluronate (HA) for Ophthalmology Market Challenges
9.4 Sodium Hyaluronate (HA) for Ophthalmology Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Sodium Hyaluronate (HA) for Ophthalmology Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Sodium Hyaluronate (HA) for Ophthalmology Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Sodium Hyaluronate (HA) for Ophthalmology Production Capacity (K MT) by Manufacturers in 2024
 Table 4. Global Sodium Hyaluronate (HA) for Ophthalmology Production by Manufacturers (2020-2025) & (K MT)
 Table 5. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Sodium Hyaluronate (HA) for Ophthalmology, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Sodium Hyaluronate (HA) for Ophthalmology as of 2024)
 Table 10. Global Market Sodium Hyaluronate (HA) for Ophthalmology Average Price by Manufacturers (USD/MT) & (2020-2025)
 Table 11. Global Key Manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, Product Offered and Application
 Table 13. Global Key Manufacturers of Sodium Hyaluronate (HA) for Ophthalmology, Date of Enter into This Industry
 Table 14. Global Sodium Hyaluronate (HA) for Ophthalmology Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Region (2020-2025)
 Table 19. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Sodium Hyaluronate (HA) for Ophthalmology Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)
 Table 22. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) by Region (2020-2025)
 Table 23. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Region (2020-2025)
 Table 24. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) Forecast by Region (2026-2031)
 Table 25. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Sodium Hyaluronate (HA) for Ophthalmology Market Average Price (USD/MT) by Region (2020-2025)
 Table 27. Global Sodium Hyaluronate (HA) for Ophthalmology Market Average Price (USD/MT) by Region (2026-2031)
 Table 28. Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)
 Table 29. Global Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region (2020-2025) & (K MT)
 Table 30. Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Market Share by Region (2020-2025)
 Table 31. Global Sodium Hyaluronate (HA) for Ophthalmology Forecasted Consumption by Region (2026-2031) & (K MT)
 Table 32. Global Sodium Hyaluronate (HA) for Ophthalmology Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)
 Table 34. North America Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2020-2025) & (K MT)
 Table 35. North America Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2026-2031) & (K MT)
 Table 36. Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)
 Table 37. Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2020-2025) & (K MT)
 Table 38. Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2026-2031) & (K MT)
 Table 39. Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)
 Table 40. Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region (2020-2025) & (K MT)
 Table 41. Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region (2026-2031) & (K MT)
 Table 42. Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)
 Table 43. Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2020-2025) & (K MT)
 Table 44. Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption by Country (2026-2031) & (K MT)
 Table 45. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) by Type (2020-2025)
 Table 46. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) by Type (2026-2031)
 Table 47. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Type (2020-2025)
 Table 48. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Type (2026-2031)
 Table 49. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Type (2020-2025)
 Table 52. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Type (2026-2031)
 Table 53. Global Sodium Hyaluronate (HA) for Ophthalmology Price (USD/MT) by Type (2020-2025)
 Table 54. Global Sodium Hyaluronate (HA) for Ophthalmology Price (USD/MT) by Type (2026-2031)
 Table 55. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) by Application (2020-2025)
 Table 56. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) by Application (2026-2031)
 Table 57. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Application (2020-2025)
 Table 58. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Application (2026-2031)
 Table 59. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Application (2020-2025)
 Table 62. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Application (2026-2031)
 Table 63. Global Sodium Hyaluronate (HA) for Ophthalmology Price (USD/MT) by Application (2020-2025)
 Table 64. Global Sodium Hyaluronate (HA) for Ophthalmology Price (USD/MT) by Application (2026-2031)
 Table 65. Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 66. Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 67. Bloomage Biotech Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 68. Bloomage Biotech Main Business and Markets Served
 Table 69. Bloomage Biotech Recent Developments/Updates
 Table 70. Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 71. Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 72. Shandong Focuschem Biotech Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Shandong Focuschem Biotech Main Business and Markets Served
 Table 74. Shandong Focuschem Biotech Recent Developments/Updates
 Table 75. Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 76. Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 77. Fufeng Group Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Fufeng Group Main Business and Markets Served
 Table 79. Fufeng Group Recent Developments/Updates
 Table 80. Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 81. Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 82. Shandong Awa Biopharm Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Shandong Awa Biopharm Main Business and Markets Served
 Table 84. Shandong Awa Biopharm Recent Developments/Updates
 Table 85. China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 86. China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 87. China Eastar Group Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. China Eastar Group Main Business and Markets Served
 Table 89. China Eastar Group Recent Developments/Updates
 Table 90. Kewpie Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 91. Kewpie Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 92. Kewpie Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Kewpie Main Business and Markets Served
 Table 94. Kewpie Recent Developments/Updates
 Table 95. Contipro Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 96. Contipro Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 97. Contipro Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Contipro Main Business and Markets Served
 Table 99. Contipro Recent Developments/Updates
 Table 100. Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 101. Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 102. Seikagaku Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Seikagaku Main Business and Markets Served
 Table 104. Seikagaku Recent Developments/Updates
 Table 105. HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 106. HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 107. HTL Biotechnology Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. HTL Biotechnology Main Business and Markets Served
 Table 109. HTL Biotechnology Recent Developments/Updates
 Table 110. Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 111. Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 112. Fidia Farmaceutici Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Fidia Farmaceutici Main Business and Markets Served
 Table 114. Fidia Farmaceutici Recent Developments/Updates
 Table 115. LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 116. LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 117. LG Life Sciences Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. LG Life Sciences Main Business and Markets Served
 Table 119. LG Life Sciences Recent Developments/Updates
 Table 120. Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 121. Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 122. Haohai Biological Technology Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Haohai Biological Technology Main Business and Markets Served
 Table 124. Haohai Biological Technology Recent Developments/Updates
 Table 125. Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 126. Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 127. Elravie (Humedix) Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Elravie (Humedix) Main Business and Markets Served
 Table 129. Elravie (Humedix) Recent Developments/Updates
 Table 130. SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Company Information
 Table 131. SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Specification and Application
 Table 132. SciVision Biotech Sodium Hyaluronate (HA) for Ophthalmology Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. SciVision Biotech Main Business and Markets Served
 Table 134. SciVision Biotech Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Sodium Hyaluronate (HA) for Ophthalmology Distributors List
 Table 138. Sodium Hyaluronate (HA) for Ophthalmology Customers List
 Table 139. Sodium Hyaluronate (HA) for Ophthalmology Market Trends
 Table 140. Sodium Hyaluronate (HA) for Ophthalmology Market Drivers
 Table 141. Sodium Hyaluronate (HA) for Ophthalmology Market Challenges
 Table 142. Sodium Hyaluronate (HA) for Ophthalmology Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sodium Hyaluronate (HA) for Ophthalmology
 Figure 2. Global Sodium Hyaluronate (HA) for Ophthalmology Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Sodium Hyaluronate (HA) for Ophthalmology Market Share by Type: 2024 VS 2031
 Figure 4. Biological Extraction Product Picture
 Figure 5. Ferment Product Picture
 Figure 6. Global Sodium Hyaluronate (HA) for Ophthalmology Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Sodium Hyaluronate (HA) for Ophthalmology Market Share by Application: 2024 VS 2031
 Figure 8. Eye Drops
 Figure 9. Eye Surgery
 Figure 10. Others
 Figure 11. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Sodium Hyaluronate (HA) for Ophthalmology Production Capacity (K MT) & (2020-2031)
 Figure 14. Global Sodium Hyaluronate (HA) for Ophthalmology Production (K MT) & (2020-2031)
 Figure 15. Global Sodium Hyaluronate (HA) for Ophthalmology Average Price (USD/MT) & (2020-2031)
 Figure 16. Sodium Hyaluronate (HA) for Ophthalmology Report Years Considered
 Figure 17. Sodium Hyaluronate (HA) for Ophthalmology Production Share by Manufacturers in 2024
 Figure 18. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Share by Manufacturers (2024)
 Figure 19. Sodium Hyaluronate (HA) for Ophthalmology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Sodium Hyaluronate (HA) for Ophthalmology Revenue in 2024
 Figure 21. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Sodium Hyaluronate (HA) for Ophthalmology Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Sodium Hyaluronate (HA) for Ophthalmology Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)
 Figure 24. Global Sodium Hyaluronate (HA) for Ophthalmology Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan Sodium Hyaluronate (HA) for Ophthalmology Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global Sodium Hyaluronate (HA) for Ophthalmology Consumption by Region: 2020 VS 2024 VS 2031 (K MT)
 Figure 30. Global Sodium Hyaluronate (HA) for Ophthalmology Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 32. North America Sodium Hyaluronate (HA) for Ophthalmology Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 34. Canada Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 35. Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 36. Europe Sodium Hyaluronate (HA) for Ophthalmology Consumption Market Share by Country (2020-2031)
 Figure 37. Germany Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 38. France Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 39. U.K. Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 40. Italy Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 41. Russia Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 42. Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 43. Asia Pacific Sodium Hyaluronate (HA) for Ophthalmology Consumption Market Share by Region (2020-2031)
 Figure 44. China Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 45. Japan Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 46. South Korea Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 47. China Taiwan Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 48. Southeast Asia Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 49. India Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 50. Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 51. Latin America, Middle East & Africa Sodium Hyaluronate (HA) for Ophthalmology Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 53. Brazil Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 54. Turkey Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 55. GCC Countries Sodium Hyaluronate (HA) for Ophthalmology Consumption and Growth Rate (2020-2031) & (K MT)
 Figure 56. Global Production Market Share of Sodium Hyaluronate (HA) for Ophthalmology by Type (2020-2031)
 Figure 57. Global Production Value Market Share of Sodium Hyaluronate (HA) for Ophthalmology by Type (2020-2031)
 Figure 58. Global Sodium Hyaluronate (HA) for Ophthalmology Price (USD/MT) by Type (2020-2031)
 Figure 59. Global Production Market Share of Sodium Hyaluronate (HA) for Ophthalmology by Application (2020-2031)
 Figure 60. Global Production Value Market Share of Sodium Hyaluronate (HA) for Ophthalmology by Application (2020-2031)
 Figure 61. Global Sodium Hyaluronate (HA) for Ophthalmology Price (USD/MT) by Application (2020-2031)
 Figure 62. Sodium Hyaluronate (HA) for Ophthalmology Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS